- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CORNERSTONE THERAPEUTICS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 92,70 | -0,43 % | Gilead Sciences Presents New Data On Twice-Yearly Lenacapavir For HIV Prevention | FOSTER CITY (dpa-AFX) - Gilead Sciences, Inc. (GILD) Monday announced that Gilead researchers and collaborators will present new Phase 3 Purpose trial data at IAS 2025 showing that twice-yearly... ► Artikel lesen | |
| ZOETIS | 126,48 | -1,05 % | Dividendenbekanntmachungen (18.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-MARK PRECIOUS METALS INC US00181T1079 0,2 USD 0,1724 EUR ACUITY INC US00508Y1029 0,17 USD 0,1465 EUR BHARTI AIRTEL LTD INE397D01024 16... ► Artikel lesen | |
| INCYTE | 57,90 | -0,82 % | Incyte: UBS erhöht Kursziel auf 62 US-Dollar aufgrund von Verkaufsaussichten | ||
| AMARIN | 14,000 | +2,19 % | Take the Zacks Approach to Beat the Markets: Amarin, Mogo, 3M in Focus | ||
| CASSAVA SCIENCES | 1,995 | +4,15 % | Cassava Sciences, Inc.: Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development | AUSTIN, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a clinical-stage biotechnology company focused on developing novel, investigational... ► Artikel lesen | |
| LIGAND PHARMACEUTICALS | 119,00 | -0,83 % | LGND AI: $9 Million Secured For Improving Earth Data | ||
| ACHIEVE LIFE SCIENCES | 2,240 | -3,66 % | Achieve Life Sciences: Trading-Chance bei Anti-Raucher-Aktie | SD-Leser kennen die Aktie von Achieve Life Sciences von früheren Höhenflügen noch gut. Immer wieder konnten wir uns gezielt Trading-Dynamiken zunutze machen und teils dreistellige Gewinne einfahren.... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 281,50 | -2,12 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 1,260 | -1,56 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
| TALPHERA | 0,313 | -5,30 % | Talphera, Inc.: Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update | Cash and investments at March 31, 2025, as adjusted to include the proceeds from the first tranche of the private placement financing which closed on April 2, 2025... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,059 | +2,61 % | Enzon Pharmaceuticals, Inc: Enzon and Viskase Enter into Merger Agreement | CRANFORD, N.J. and LOMBARD, Ill., June 20, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQX: ENZN) ("Enzon" or the "Company") and Viskase Companies, Inc. (OTC Pink Limited: VKSC) ("Viskase")... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 58,00 | +0,87 % | ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin Gel for the Treatment of Acute Gout Flares | Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be conducted by Dr. Hyon Choi at Massachusetts General Hospital and will compare... ► Artikel lesen | |
| RIGEL PHARMACEUTICALS | 16,700 | +3,09 % | Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | SOUTH SAN FRANCISCO, Calif., July 7, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant... ► Artikel lesen | |
| SAVARA | 1,960 | +0,51 % | Savara Inc.: Savara Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at Two Upcoming Scientific Conferences | Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, announced encore presentations of top-line data from the pivotal, Phase... ► Artikel lesen | |
| MOLECULAR TEMPLATES | 0,107 | -0,56 % | NSE - Molecular Templates, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities |
CORNERSTONE THERAPEUTICS INC gehört der Branche Pharma an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORNERSTONE THERAPEUTICS INC finden Sie auf Wallstreet Online.